Joseph Erinjeri, MD
Vascular & Interventional Radiology · New York, NYNPI 1437289048
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $41,893 of the $55,262 with a category attached, or 75.8%. AstraZeneca accounts for 71.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $20,213 and has fallen 89.2% since, to $2,182 in 2025. Among vascular & interventional radiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $969.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$39K
- Astrazeneca UK Limited$13K
- Inari Medical, Inc.$990
- Histosonics, Inc.$729
- Trisalus Life Sciences, Inc.$340
- Argon Medical Devices, Inc.$330
- plus $567 from 4 others
Across 3 payments — averaging $14,057 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$42K
What the payments were for
- Consulting fees$41,89376%
- Speaking & faculty fees$1,3843%
- Travel & lodging$9,08216%
- Food & beverage$2,9045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $39,226 |
| Astrazeneca UK Limited | 20 | $13,080 |
| Inari Medical, Inc. | 9 | $990 |
| Histosonics, Inc. | 1 | $729 |
| Trisalus Life Sciences, Inc. | 3 | $340 |
| Argon Medical Devices, Inc. | 6 | $330 |
| BTG International Canada Inc. | 1 | $154 |
| Galvanize Therapeutics, Inc | 1 | $149 |
| Cook Medical LLC | 1 | $134 |
| Boston Scientific | 1 | $130 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$21,630
- CT THROMBECTOMY SYSTEM KIT$814
- FLOWTRIEVER CATHETER, S$814
- TRINAV INFUSION SYSTEM$306
- THERASPHERE-BIO$154
- ALIYA SYSTEM$149
- Tornado$134
- THERASPHERE$130
How this compares
$55,262 in reported general payments places this provider in the 90th percentile of 306 vascular & interventional radiology providers in New York.
See all vascular & interventional radiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in New York
- Edward KimNew York$831K
- Robert LooksteinNew York$515K
- Rahul PatelNew York$275K
- Aaron FischmanNew York$240K
- Philip MeyersNew York$238K
- Abigail FalkNew York$214K
- Robert RosenNew York$199K
- Asad BaigNew York$137K
- Joshua WeintraubNew York$137K
- Joseph ShamsNew York$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.